Senate Committee Approves Stephen Hahn’s Nomination as FDA Head
Dr. Stephen Hahn is just one step away from becoming the next commissioner of the U.S. Food & Drug Administration (FDA).
The Senate Health, Education, Labor and Pensions Committee approved Hahn’s nomination by a vote of 18-5. His nomination now moves to its final step, a vote by the full Senate.
Hahn is a cancer specialist who is currently the chief medical executive of MD Anderson, the famous cancer hospital in Houston. He previously worked for the National Cancer Institute and the University of Pennsylvania.
While he faced a number of questions about e-cigarettes and vaping products, Hahn’s thoughts on cigars—and more specifically, premium cigars—are unknown.
If approved Hahn will be the fourth person to lead FDA in a year. Dr. Scott Gottlieb left the agency in April, he was replaced by Dr. Ned Sharpless on a temporary basis, however, Sharpless’s tenure ended last month as he reached the maximum amount of time he could serve as an interim commissioner. The agency is currently led by Dr. Brett Giroir.
Charlie Minato
I am an editor and co-founder of halfwheel.com/Rueda Media, LLC. I previously co-founded and published TheCigarFeed, one of the two predecessors of halfwheel. I have written about the cigar industry for more than a decade, covering everything from product launches to regulation to M&A. In addition, I handle a lot of the behind-the-scenes stuff here at halfwheel. I enjoy playing tennis, watching boxing, falling asleep to the Le Mans 24, wearing sweatshirts year-round and eating gyros. echte liebe.
Related Posts
-
November 1, 2019 -
February 28, 2017
